Clinical Trials Browser

Phase 1 × INDUSTRY × LFB-R603 × Clear all

NCT04806035 2024-07-31

Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Terminated

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT03804996 2024-04-08

Study of TG-1801 in Subjects With B-Cell Lymphoma

Phase 1 Completed

Recurrence, Lymphoma, B-Cell

NCT01098188 2012-04-30

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell